21
De Carvalho Scamilla, Aledo Maria Aparecida, Meizanis James J, Oliveira D Artagnan Silva, Rangel Fabio Eduardo Franca: Coating useful as a dispenser of an active ingredient on dressings and bandages. Johnson & Johnson Consumer Companies, CIAMPORCERO Audley A Jr, June 2, 2000: WO/2000/030694

The dressings of the invention comprise at least two components: an absorbent substrate having a first skin-facing surface and a second opposing surface; and a discontinuous coating of a semi-solid composition having an ointment-like feel overlying a portion of the first surface of said absorbent su ...


22
Upmalis David H: Mcneil Ppc, CIAMPORCERO Audley A Jr, June 2, 2000: WO/2000/030626

A method for treating vulvovaginal candidiasis including the steps of: (a) administering a single dose of an effective amount of miconazole nitrate in a pharmaceutically acceptable carrier intra-vaginally; and (b) applying miconazole nitrate in a pharmaceutically acceptable carrier to the vulva. Als ...


23
Dax Scott L, Lovenberg Timothy W, Baxter Ellen W, Carson John R, Ludovici Donald W, Youngman Mark A: N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor. Ortho Mcneil Pharmaceutical, CIAMPORCERO Audley A Jr, April 13, 2000: WO/2000/020376

$g(b)-Aminotetralin derivatives of formula (I) which are ligands for the neuropeptide Y Y5 (NPY5) receptor, methods of preparation and pharmaceutical compositions containing a $g(b)-aminotetralin derivative as the active ingredient are described. The $g(b)-aminotetralins are useful in the treatment ...


24
Lovenberg Timothy W, Erlander Mark, Huvar Arne, Pyati Jayashree: Isolated dna encoding human h3 histamine receptor. Ortho Mcneil Pharmaceutical, CIAMPORCERO Audley A Jr, April 13, 2000: WO/2000/020011

DNAs encoding the human histamine H3 receptor have been cloned and characterized. The recombinant protein is capable of forming biologically active histamine H3 receptor protein. The cDNAs have been expressed in recombinant host cells which produce active recombinant protein. The recombinant protein ...


25
Vyakarnam Murty N, Roller Mark B, Gorky David V, Scopelianos Angelo George: Process for manufacturing biomedical foams. Ethicon, CIAMPORCERO Audley A Jr, January 11, 2001: WO/2001/002033

The present invention provides an improved lyophilization process for forming biocompatible foam structures. The process allows the foam structures to be tailored for specific end uses. The foams formed by this process are well suited to be used in medical applications such as tissue engineering. Th ...


26
Yu Danny, Roche Edward: Taste masked pharmaceutical liquid formulations. Ortho Mcneil Pharmaceutical, CIAMPORCERO Audley A Jr, January 18, 2001: WO/2001/003698

A liquid composition for oral administration comprising a pharmaceutically active medicament coated with a taste masking effective amount of a polymer blend of (a) dimethylaminoethyl methacrylate and neutral methacrylic acid ester (MM/MAE) and (b) a cellulose ester, in an aqueous vehicle, wherein th ...


27
Abdel Magid Ahmed F, Harris Bruce D, Maryanoff Cynthia A: Process for preparing 1,5-diaryl-3-substituted pyrazoles. Ortho Mcneil Pharmaceutical, CIAMPORCERO Audley A Jr, February 8, 2001: WO/2001/009102

A process for making a compound of formula (I) wherein the substituents are as described in the specification comprising reacting a ketone of formula (II) with succinic anhydride and an alkoxide base to form a compound of formula (III) which is reacted with a compound of formula (IV) to form a compo ...


28
Dax Scott L, Mcnally James, Youngman Mark: Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders. Ortho Mcneil Pharmaceutical, CIAMPORCERO Audley A Jr, February 8, 2001: WO/2001/009120

Amine and amide derivatives of formula (A) which are ligands for the neuropeptide Y Y5 (NPY5) receptor, methods of preparation and pharmaceutical compositions containing amines and amides of formula (A) as the active ingredient are described. The amines and amides of formula (A) are useful in the tr ...


29
Bezwada Rao S, Jamiolkowski Dennis D: Method of preventing adhesions with absorbable polyoxaesters. Ethicon, CIAMPORCERO Audley A Jr, February 22, 2001: WO/2001/012203

The present invention describes a method of preventing adhesion formation between tissues in an animal by placing a sterile polyoxaester adhesion prevention barrier between the tissues of the animal to prevent an adhesion from forming.


30
Lee Andrew Shu Tsung, Newman Anthony Wayne: Personal cleansing composition. Ethicon, CIAMPORCERO Audley A Jr, December 7, 2000: WO/2000/072807

A personal cleansing composition is provided which comprises: a) at least one polymeric isobutene having from about 12 to about 156 carbon atoms, wherein the polymeric isobutene is liquid at room temperature and pressure; b) at least one dicarboxylic acid having formula (I) or a cosmetically accepta ...